Novavax’s coronavirus vaccine generates promising immune response in early trial, data shows
https://www.cnbc.com/2020/08/04/novavaxs-coronavirus-vaccine-shows-promise-in-early-stage-trial.html
I think Novavax study held by Queensland university also , Novavax share up more than 10% after market closed trade
- Forums
- ASX - By Stock
- CSL
- Short CSL ? HCQ is the Cure
Short CSL ? HCQ is the Cure, page-24
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$285.54 |
Change
-1.120(0.39%) |
Mkt cap ! $138.2B |
Open | High | Low | Value | Volume |
$285.50 | $285.86 | $282.18 | $110.7M | 388.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 368 | $285.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$285.54 | 425 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 251 | 285.310 |
1 | 123 | 285.280 |
1 | 138 | 285.200 |
1 | 80 | 285.100 |
1 | 985 | 285.020 |
Price($) | Vol. | No. |
---|---|---|
285.540 | 425 | 1 |
285.600 | 810 | 1 |
285.670 | 916 | 1 |
285.760 | 842 | 1 |
285.770 | 303 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online